FunPep Co., Ltd.
- Biotech or pharma, therapeutic R&D
FunPep (4881.T) is a Phase 3 clinical stage therapeutics company with a functional peptide and antibody-inducing peptide platform. Our assets and platform have generated a large amount of positive data with our Phase 3 asset and a Phase 1 asset licensed to Shionogi, a Phase 2 asset optioned by Sumitomo, and two ongoing R&D collaborations. Our focus at BIO is to partner our IND ready Migraine vaccine as well as find collaboration for our platform.
)
)
){kind=logo}
){kind=logo}
){kind=logo}